News
Wave's stock wavers on obesity drug data

Wave's stock wavers on obesity drug data

Wave Life Sciences has said new clinical trial results with its non-incretin therapy for weight loss are positive – but investors don't seem to agree.

Featured Content

Newsletters and Deep Dive
digital magazine

Latest News

News
Wave's stock wavers on obesity drug data

Wave's stock wavers on obesity drug data

Wave Life Sciences has said new clinical trial results with its non-incretin therapy for weight loss are positive – but investors don't seem to agree.

Views & Analysis

White Papers & Webinar

Podcasts & Video

Partner Content